Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Alzheimer Disease”

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT01181921
What this trial is testing

The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen-Cilag, S.A. 1
Not applicableEnded earlyNCT02249468
What this trial is testing

An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population

Who this might be right for
Mild and Moderate Alzheimer's DiseaseCognitively Healthy People
Danone Nutricia Research 191
Large-scale testing (Phase 3)Study completedNCT00838110
What this trial is testing

Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 742
Not applicableStudy completedNCT06151808
What this trial is testing

Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects

Who this might be right for
Alzheimer Disease
Sinotau Pharmaceutical Group 42
Early research (Phase 1)Study completedNCT00965588
What this trial is testing

Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
United Biomedical 19
Not applicableEnded earlyNCT03672474
What this trial is testing

REGEnLIFE RGn530 - Feasibility Pilot

Who this might be right for
Alzheimer Disease
University Hospital, Montpellier 60
Early research (Phase 1)Study completedNCT04040348
What this trial is testing

Alzheimer's Disease Stem Cells Multiple Infusions

Who this might be right for
Alzheimer Disease
Bernard (Barry) Baumel 6
Large-scale testing (Phase 3)Looking for participantsNCT06534723
What this trial is testing

Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)

Who this might be right for
Alzheimer's Dementia
Sichuan Jishengtang Pharmaceutical Co., Ltd. 570
Testing effectiveness (Phase 2)Study completedNCT05189210
What this trial is testing

GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Mild to Moderate Alzheimer's Disease
GemVax & Kael 199
Testing effectiveness (Phase 2)Study completedNCT02431468
What this trial is testing

A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Neurotrope Bioscience, Inc. 147
Early research (Phase 1)Study completedNCT01369225
What this trial is testing

Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 52
Not applicableUnknownNCT05114499
What this trial is testing

Efficacy and Safety of Donepezil and Sodium Oligomannate in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
First Affiliated Hospital Xi'an Jiaotong University 150
Early research (Phase 1)Study completedNCT03635047
What this trial is testing

A Phase I Study for Safety and Tolerability of AL002.

Who this might be right for
HealthyAlzheimer Disease
Alector Inc. 69
Testing effectiveness (Phase 2)Study completedNCT01549834
What this trial is testing

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 434
Not applicableStudy completedNCT03349320
What this trial is testing

Response to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic Polymorphisms

Who this might be right for
Late Onset Alzheimer Disease
Federal University of Minas Gerais 37
Testing effectiveness (Phase 2)Study completedNCT02359552
What this trial is testing

Rasagiline Rescue in Alzheimer's Disease Clinical Trial

Who this might be right for
Alzheimer's Disease
The Cleveland Clinic 50
Large-scale testing (Phase 3)Study completedNCT00090116
What this trial is testing

The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Forest Laboratories 400
Very early researchStudy completedNCT06489015
What this trial is testing

Recombinant Human Serum Albumin in the Treatment of Mild-to-moderate AD (Alzheimer's Disease) Exploratory Clinical Trial

Who this might be right for
Alzheimer's Disease (AD)
Shenzhen Protgen Co., Ltd. 30
Not applicableUnknownNCT03773016
What this trial is testing

Touchscreen Technology and Art for People With Dementia in Care Homes

Who this might be right for
Mild DementiaModerate Dementia
University of Nottingham 12
Large-scale testing (Phase 3)UnknownNCT01094340
What this trial is testing

Thalidomide for Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Banner Health 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation